Genes, Chromosomes and Cancer (GCC)

Genes, Chromosomes & Cancer is a long-standing scientific journal founded in 1989 and published by Wiley-Blackwell, dedicated to advancing understanding of the genetic and chromosomal alterations that drive cancer. It serves as an international forum for high-quality research that explores mechanisms at the intersection of genetics, cytogenetics and oncology. The journal covers a wide range of topics including chromosomal abnormalities, gene fusions, mutation spectra, gene expression changes, comparative genomic studies, and functional analyses of oncogenes and tumor suppressor genes. Contributions include full-length original research articles, comprehensive reviews, and insightful commentaries that address both fundamental biological questions and clinical implications of genetic discoveries in cancer. Its monthly publication schedule ensures timely dissemination of cutting-edge findings to researchers, clinicians, and policy makers globally. The journal plays a crucial role in fostering interdisciplinary dialogue across laboratory and clinical oncology, highlighting how chromosomal and genetic insights can influence diagnostic approaches, therapeutic strategies and our overall understanding of neoplastic transformation. Genes, Chromosomes & Cancer is indexed in major scientific databases and maintains rigorous peer review standards to ensure scientific integrity and impact.

Genes, Chromosomes and Cancer (GCC) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cancer Research, Genetics, genetic and chromosomal mechanisms underlying neoplasia and cancer development, as well as molecular and cellular findings relevant to diagnosis, pathogenesis and clinical management of cancer, The journal publishes original research articles, perspectives, reviews and letters to the editor, aiming to communicate new insights in genetic analysis related to neoplastic disorders , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1045-2257, E-ISSN: 1098-2264, Established: 1989, Impact Factor: 2.8
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE